⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9959979 | 1.00 | — | — | |
| SCHEMBL10938854 | 0.89 | — | — | |
| SCHEMBL9712160 | 0.82 | — | — | |
| SCHEMBL11451258 | 0.82 | — | — | |
| SCHEMBL547054 | 0.81 | — | — | |
| SCHEMBL7065528 | 0.81 | — | — | |
| SCHEMBL14896300 | 0.81 | — | — | |
| SCHEMBL15733282 | 0.81 | — | — | |
| SCHEMBL2043596 | 0.81 | — | — | |
| SCHEMBL8355186 | 0.81 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5019568-A | Steroidal glycolipids as host resistance stimulators against viral infection | MERCK & CO., INC. (US) | 1991-05-28 | — | — | US | disclosed |
| US-4970199-A | ADMINISTERING WITH ANTI-AIDS DRUGS | MERCK & CO., INC. (US) | 1990-11-13 | — | — | US | disclosed |
| EP-0224173-A1 | Steroidal glycolipids as host resistance stimulators | MERCK & CO. INC. (US) | 1987-06-03 | — | — | EP | disclosed |
| EP-0007277-B1 | NEW GLYCOLIPID COMPOUND USEFUL AS IMMUNOLOGIC ADJUVANT AND ITS PREPARATION | MERCK & CO. INC. (US) | 1983-02-09 | — | — | EP | disclosed |
| EP-0063373-A1 | Cell-specific glycopeptide ligands | MERCK & CO. INC. (US) | 1982-10-27 | — | — | EP | disclosed |